A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP
A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP

Genscript Biotech posts best gain in 15 months after US regulator approves use of Covid-19 neutralising antibodies test kit

  • Company claims its cPass kit is the first commercially available test to specifically detect neutralising antibodies without the use of live virus
  • Tests can be completed in an hour and does not require biosafety containment, Genscript says

Topic |   Coronavirus China
A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP
A Chinese citizen undergoes a swab test for the Covid-19 coronavirus. Genscript Biotech has developed a rapid test kit that can detect neutralising antibodies in a person and can be completed in an hour. Photo: AFP
READ FULL ARTICLE